Project Grant R43AG094486
Award Date 9/16/25
Completion Date 5/31/27
Dollars Obligated $326K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- The federal Project Grant award of $654,367.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant, awarded on January 1, 2025, supports research to investigate the neural mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 (PASC), also known as "Long COVID". The research aims to determine the relationship...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to investigate the mechanisms by which SARS-CoV-2 infection causes neurological damage, leading to a syndrome known as Post-Acute Sequelae of COVID-19 (PASC) or "NeuroPASC". The total award amount is $634,622.00 over the project period from December 1, 2024 to November 30,...
- This Project Grant award of $797,157 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will support research to understand the impact of post-acute sequelae of SARS-CoV-2 infection (PASC) on brain function and cognitive impairment. The research will be conducted by Yale University, leveraging their expertise in neuroscience, neuroimaging, and the established COVID Mind Study. The project aims to identify circuit-level brain...
- This $457,778 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of a human microphysiological system (MPS) to investigate the peripheral nervous system (PNS) neurotropism of respiratory syncytial virus (RSV) and SARS-CoV-2. The research aims to elucidate the underlying mechanisms contributing to chronic neurological impairments associated with RSV and...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research program) provides $1,998,535 to Pascall Systems, Inc. to commercialize their neuroscience-based EEG-guided precision anesthesia management system. The key products and services being delivered include: Pilot study to determine sample size, cost, and timeline for a Phase III multi-site clinical trial to optimize workflows, outcome measures, and caregiver protocol adherence for the Pascall M1 device....
- This $500,000 Project Grant was awarded on September 15, 2024 by the National Institute on Aging (CFDA 93.866 Aging Research program) to Neucyte Inc., a minority-owned small business specializing in advanced biomedical research and development. The funding will support the development of a miniaturized "mini-brain" microphysiological system (MPS) platform using Alzheimer's disease (AD) patient-derived cells. The goal is to create a scalable, reproducible in vitro brain model that can...
- This $497,201 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is focused on developing a software-as-a-service (SaaS) solution called "MindCount" that can provide highly sensitive and accessible measures of mental functioning for patients recovering from traumatic brain injury (TBI). The goal is to create an objective...
- The National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), awarded a $459,097 Project Grant to Pison Technology, Inc., a minority-owned small business in Boston, Massachusetts. The grant, awarded on June 12, 2025, will fund the development of a digital biomarker for amyotrophic lateral sclerosis (ALS) using Pison's wrist-worn neural biosensor device. The goal is to leverage the...
- This $375,840 Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) supports the development of advanced machine learning models to enable accurate and early prediction of Alzheimer's disease and related dementias (ADRD). The project, led by the University of Virginia, will leverage novel natural language processing techniques to automatically extract personal risk factors for ADRD from electronic health...
- The National Institute on Aging (NIA) awarded a 3-year, $2,561,480 Project Grant (CFDA 93.866) to Brigham & Women's Hospital to study the post-acute sequelae of SARS-CoV-2 infection (PASC) and subsequent disease progression in individuals with mild cognitive impairment (MCI) or Alzheimer's disease (AD) and related dementias (ADRD). The project aims to: 1) understand the epidemiology of PASC in cognitively impaired individuals; 2) examine the impacts of COVID-19 and PASC on disease...